North America Viral Vector And Plasmid DNA Manufacturing Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 November 28
SKU : HCIT5168
excelpdfpowerpoint
180 pages
Report Summary
loading
Buy this report
Single User
$3750
Multiple User
$4000
Enterprise User
$7250
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the North America Viral Vector And Plasmid Dna Manufacturing Market ?
North America Viral Vector And Plasmid Dna Manufacturing Market is expected to grow at a CAGR of 2.8% during the forecast period 2023-2030.
Who are the key players in the North America Viral Vector And Plasmid Dna Manufacturing Market ?
Major players are Lonza, Merck, Oxford BioMedica, CGT Catapult, Cobra Biologics, UniQure, Sanofi, FUJIFILM Diosynth Biotechnologies, Cobra Biologics, Thermo Fisher Scientific, Inc. and Spark Therapeutics.
Related Reports
pharmaceuticals

In Vitro Toxicology Testing Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 22
Starting from

$4350

healthcare-it

Medical Image Analysis Software Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 05
Starting from

$4350

healthcare-it

Europe Medical Image Analysis Software Market Size, Share, and Outlook (2023-2030)

Published: 2023 October 23
Starting from

$3750

healthcare-it

Mobile Health Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 05
Starting from

$4350

healthcare-it

Healthcare Analytics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 05
Starting from

$4350

healthcare-it

Laboratory Information Management Systems Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 08
Starting from

$4350